The present invention provides compounds, which, are novel antagonists for
D.sub.1/D.sub.5 receptors as well as methods for preparing such
compounds. In another embodiment, the invention provides pharmaceutical
compositions comprising such D.sub.1/D.sub.5 receptor antagonists as well
as methods of using them to treat CNS disorders, obesity, metabolic
disorders, eating disorders such as hyperphagia, and diabetes.
A invenção atual fornece os compostos, que, são antagonistas da novela para os receptors D.sub.1/D.sub.5 as.well.as métodos para preparar tais compostos. Em uma outra incorporação, a invenção fornece as composições pharmaceutical que compreendem tais antagonistas do receptor D.sub.1/D.sub.5 as.well.as métodos de usá-los tratar disorders do CNS, obesity, disorders metabolic, comendo disorders tais como o hyperphagia, e diabetes.
